Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory Mantle Cell Lymphoma; Results of a Phase II TrialAna García-Noblejas,Eulogio Conde,Alejandro Martín,María Jesús Vidal,Rafael Rojas,Carlos Grande, María José Ramírez, Jimena Cannata-Ortiz,Juan Carlos García-Ruiz,Javier Briones,Andres Lopez, Pablo Ríos Rull,Victor Noriega,Guillermo Deben,Eva González Barca,Sonia González de Villambrosia, José Javier Ferreiro,Juan José Lahuerta,Maria Dolores Caballero,Reyes ArranzBlood（2014）引用 29|浏览24暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
